Development of new osteoporosis health outcomes model
We are developing a microsimulation health economics model for the assessment of cost-effectiveness of osteoporosis treatment and fracture prevention. The model has been built in TreeAge decision analysis software and analyses the value for money of different screening and medications in the prevention of fragility-related hip, vertebral, wrist and other fractures.
The model has been adapted to make population projections of burden and costs of fractures in China, and has already been published numerous times in leading international journals. We will continue to refine the model and adapt it to other country-specific settings.
Research Groups
Related Diseases
Staff
Senior Members
- Professor Andrew Palmer (New Star Professor)
Doctoral Students
- Lei Si